Guangyao Group's Baiyunshan Compound Banlangen Granule (low sugar) was successfully approved for Macao Chinese patent medicine registration certificate, which is the first oral innovative new drug approval issued by the same name since the implementation of Macao's Law on the Registration of Traditional Chinese Medicine and Chinese Patent Medicine and the unveiling of Macao Drug Administration.